Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312911 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kun-Chi Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Regeneration, Mesenchymal Stem Cell Transplantation, Aging. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSTC.
Abstract (Originalsprache)
Cartilage degeneration is a key feature of aging and osteoarthritis, characterized by the progressive deterioration of joint function, pain, and limited mobility. Current treatments focus on symptom relief, not cartilage regeneration. Mesenchymal stromal cells (MSCs) offer a promising therapeutic option due to their capability to differentiate into chondrocytes, modulate inflammation, and promote tissue regeneration. This review explores the potential of MSCs for cartilage regeneration, examining their biological properties, action mechanisms, and applications in preclinical and clinical settings. MSCs derived from bone marrow, adipose tissue, and other sources can self-renew and differentiate into multiple cell types. In aging cartilage, they aid in tissue regeneration by secreting growth factors and cytokines that enhance repair and modulate immune responses. Recent preclinical studies show that MSCs can restore cartilage integrity, reduce inflammation, and improve joint function, although clinical translation remains challenging due to limitations such as cell viability, scalability, and regulatory concerns. Advancements in MSC delivery, including scaffold-based approaches and engineered exosomes, may improve therapeutic effectiveness. Potential risks, such as tumorigenicity and immune rejection, are also discussed, emphasizing the need for optimized treatment protocols and large-scale clinical trials to develop effective, minimally invasive therapies for cartilage regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.
- Department of Pediatrics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.
- Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.
- Institute of Medical Sciences, College of Medicine, Tzu Chi University, Hualien 970, Taiwan.
- Department of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.
ORCID-Profile: Dah-Ching Ding, Shinn-Zong Lin
Förderung
- NSTC
Zitieren
APA
Wu, K. C., Chang, Y. H., Ding, D. C., & Lin, S. Z. (2024). Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312911
Vancouver
Wu KC, Chang YH, Ding DC, Lin SZ. Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312911
BibTeX
@article{Wu2024,
author = {Wu, Kun-Chi and Chang, Yu-Hsun and Ding, Dah-Ching and Lin, Shinn-Zong},
title = {Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312911}
}
EUVIMED